Kamada (KMDA) Gross Profit (2012 - 2026)
Kamada (KMDA) posted quarterly Gross Profit of $19.1 million for Q1 2026, down 7.87% year-on-year from $20.7 million in Q1 2025, and up 12.67% on a QoQ basis from $17.0 million in Q4 2025.
Kamada (KMDA) Gross Profit (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Gross Profit for 15 consecutive years, with $19.1 million the latest figure, recorded in Q1 2026.
- Quarterly Gross Profit fell 7.87% year-over-year to $19.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 billion (changed 0.11% YoY) and the FY2025 annual result came in at $76.4 million, up 9.2% from the prior year.
- Gross Profit advanced to $19.1 million in Q1 2026 per KMDA's latest filing, from $17.0 million in the prior quarter.
- Over the last five years, Gross Profit for KMDA reached as high as $19.0 billion in Q2 2024 and fell as low as $7.2 million in Q2 2022.
- A 5-year average of $3.7 billion and a median of $17.0 million in 2024 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2022 — Gross Profit surged 224507.33% — and 2023, when it sank 99.88%.
- Year by year, Gross Profit stood at $15.3 million in 2022, then slipped by 5.75% to $14.4 million in 2023, then gained by 18.17% to $17.0 million in 2024, then decreased by 0.38% to $17.0 million in 2025, then grew by 12.67% to $19.1 million in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $19.1 million, $17.0 million, and $19.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.12 Mn |
| Mar 31, 2026 | 19.12 Mn |
| Dec 31, 2025 | 16.97 Mn |
| Dec 31, 2025 | 16.97 Mn |
| Sep 30, 2025 | 19.76 Mn |
| Sep 30, 2025 | 19.76 Mn |
| Jun 30, 2025 | 18.93 Bn |
| Jun 30, 2025 | 18.93 Bn |
| Mar 31, 2025 | 20.75 Mn |
| Mar 31, 2025 | 20.75 Mn |
| Dec 31, 2024 | 17.03 Mn |
| Dec 31, 2024 | 17.03 Mn |
| Sep 30, 2024 | 17.23 Mn |
| Sep 30, 2024 | 17.23 Mn |
| Jun 30, 2024 | 18.95 Bn |
| Jun 30, 2024 | 18.95 Bn |
| Mar 31, 2024 | 16.75 Mn |
| Mar 31, 2024 | 16.75 Mn |
| Dec 31, 2023 | 14.41 Mn |
| Dec 31, 2023 | 14.41 Mn |